Improving the representativeness of behavioral and clinical surveillance for persons with HIV in the United States: The rationale for developing a population-based approach

PLoS ONE

Volumn 2, Issue 6, 2007, Pages

  McNaghten, A D ^a   Wolfe, Mitchell I ^a   Onorato, Ida ^a   Nakashima, Allyn K ^a   Valdiserri, Ronald O ^a   Mokotoff, Eve ^b   Romaguera, Raul A ^a   Kroliczak, Alice ^c   Janssen, Robert S ^a   Sullivan, Patrick S ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

^c HEALTH RESOURCES AND SERVICES ADMINISTRATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ACCURACY; ARTICLE; DISEASE SURVEILLANCE; EPIDEMIC; HEALTH BEHAVIOR; HEALTH CARE ACCESS; HEALTH CARE DELIVERY; HEALTH CARE NEED; HEALTH CARE ORGANIZATION; HEALTH CARE PLANNING; HEALTH CARE UTILIZATION; HELP SEEKING BEHAVIOR; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; POPULATION RESEARCH; PREVENTIVE HEALTH SERVICE; SEXUAL BEHAVIOR; SUBSTANCE ABUSE; UNITED STATES; DISEASE TRANSMISSION; HEALTH SURVEY; PATHOGENICITY; UTILIZATION REVIEW;

HEALTH BEHAVIOR; HIV; HIV INFECTIONS; HUMANS; POPULATION SURVEILLANCE; PREVENTIVE HEALTH SERVICES; UNITED STATES;

EID: 35648955978     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0000550     Document Type: Article

References (59)

1. Nakashima, AK, Fleming PL (2003) HIV/AIDS surveillance in the United States, 1981-2001. J Acquir Immune Defic Syndr 32 Suppl 1: S68-S85.
2. Centers for Disease Control and Prevention (1985) Revision of the case definition of acquired immunodeficiency syndrome for national reporting- United States. MMWR Morb Mortal Wkly Rep 34: 373-375.
3. Glynn MK, Lee LM, McKenna MT (2007) The status of national HIV case surveillance, United States 2006. Pub Health Rep 122 (Supp 1): 63-72.
4. Rosenberg PS, Biggar RJ (1998) Trends in HIV incidence among young adults in the United States. JAMA 279: 1894-1899.
5. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860.
6. Centers for Disease Control and Prevention (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41: 1-19.
7. Chaisson RE, Stanton DL, Gallant JE, Rucker S, Bartlett JG, et al. (1993) Impact of die 1993 revision of the AIDS case definition on the prevalence of AIDS in a clinical setting. AIDS 7: 857-862.
8. Karon JM, Green TA, Hanson DL, Ward JW (1997) Estimating the number of AIDS-defining opportunistic illness diagnoses from data collected under the 1993 AIDS surveillance definition. J Acquir Immune Defic Syndr Hum Retrovirol 16: 116-121.
9. Farizo KM, Buehler JW, Chamberland ME, Whyte BM, Froelicher ES, et al. (1992) Spectrum of disease in persons with human immunodeficiency virus infection in the United States. JAMA 267: 1798-1805.
10. Kaplan JE, Masur H, Holmes KK (2002) Guidelines for preventing opportunistic infections among HIV-infected persons-2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. MMWR Recomm Rep 51: 1-52.
11. Dworkin MS, Hanson DL, Kaplan JE, Jones JL, Ward JW (2000) Risk for preventable opportunistic infections in persons with AIDS after antiretroviral therapy increases CD4+T lymphocyte counts above prophylaxis thresholds. J Infect Dis 182: 611-615.
12. Dworkin MS, Hanson DL, Navin TR (2001) Survival of patients with AIDS, after diagnosis of Pneumocystis carinii pneumonia, in the United States. J Infect Dis. 183: 1409-1412.
13. Hanson DL, Chu SY, Farizo KM, Ward JW (1995) Distribution of CD4+T lymphocytes at diagnosis of acquired immunodeficiency syndrome-defining and other human immunodeficiency virus-related illnesses. The Adult and Adolescent Spectrum of HIV Disease Project Group. Arch Intern Med 155: 1537-1542.
14. Jones JL, Hanson DL, Dworkin MS, DeCock KM (2000) HIV-associated tuberculosis in the era of highly active antiretroviral therapy. The Adult/Adolescent Spectrum of HIV Disease Group. Int J Tuberc Lung Dis 4: 1026-1031.
15. Jones JL, Hanson DL, Dworkin MS, Jaffe HW (2000) Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 24: 270-274.
16. McNaghten AD, Hanson DL, Dworkin MS, Jones JL (2003) Differences in prescription of antiretroviral therapy in a large cohort of HIV-infected patients. J Acquir Immune Defic Syndr 32: 499-505.
17. McNaghten AD, Hanson DL, Jones JL, Dworkin MS, Ward JW (1999) Effects of antiretroviral therapy and opportunistic illness primary chemoprophylaxis on survival after AIDS diagnosis. Adult/Adolescent Spectrum of Disease Group. AIDS 13: 1687-1695.
18. Centers for Disease Control and Prevention (1992) 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 41: 1-19.
19. Buehler JW, Diaz T, Hersh BS, Chu SY (1996) The supplement to HIV-AIDS Surveillance project: an approach for monitoring HIV risk behaviors. Public Health Rep 111 Suppl 1: 133-7, 133-137.
20. Campsmith ML, Nakashima AK, Jones JL (2000) Association between crack cocaine use and high-risk sexual behaviors after HIV diagnosis. J Acquir Immune Defic Syndr 25: 192-198.
21. Campsmith ML, Nakashima AK, Davidson AJ (2003) Self-reported health-related quality of life in persons with HIV infection: results from a multi-site interview-project. Health Qual Life Outcomes 1: 12.
22. Diaz T, Chu SY, Frederick M, Hermann P, Levy A, et al. (1993) Sociodemographics and HIV risk behaviors of bisexual men with AIDS: results from a multistate interview project. AIDS 7: 1227-1232.
23. Diaz T, Chu SY (1993) Crack cocaine use and sexual behavior among people with AIDS. JAMA 269: 2845-2846.
24. Lansky A, Nakashima AK, Jones JL (2000) Risk behaviors related to heterosexual transmission from HIV-infected persons. Supplement to HIV/ AIDS Surveillance Study Group. Sex Transm Dis 27:483-489.
25. Sullivan PS, Nakashima AK, Purcell DW, Ward JW, (1998) Geographic differences in noninjection and injection substance use among HIV-seropositive men who have sex. with men: western United States versus other regions. Supplement to HIV/AIDS Surveillance Study Group. J Acquir Immune Defic Syndr Hum Retrovirol 19: 266-273.
26. Centers for Disease Control and Prevention (2003) Late versus early testing of HIV-16 Sites, United States, 2002-2003. MMWR Morb Mortal Wkly Rep 52: 581-586.
27. Montgomery JP, Mokotoff ED, Gentry AC, Blair JM (2003) The extent of bisexual behaviour in HIV-infected men and implications for transmission to their female sex partners. AIDS Care 15: 829-837.
28. Fleming PL, Wortley PM, Karon JM, DeCock KM, Jansten RS (2000) Tracking the HIV epidemic: current issues, future challenges. Am J Public Health 90: 1037-1041.
29. Palella FJ Jr, Delaney KM, Moorman AC, Loveless MO, Fuhrer J, et al. (1998) Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators. N Engl J Med 338: 853-860.
30. Centers for Disease Control and Prevention (2003) late versus early testing of HIV-16 Sites, United States, 2000-2003. MMWR Morb Mortal Wkly Rep 52: 581-586.
31. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK (2002) Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recomm Rep 51: 1-55.
32. Kellerman SE, Lehman JS, Lansky A, Stevens MR, Hecht FM, et al. (2002) HIV testing within at-risk populations in the United States and the reasons for seeking or avoiding HIV testing. J Acquir Immune Defic Syndr 31: 202-210.
33. Neal J, Fleming P. Frequency and predictors of late HIV diagnosis in the United States, 1994 through 1999. Abstracts of the 9th Conference on Retroviruses and Opportunistic Infections. 2002.
34. Centers for Disease Control and Prevention (2003) Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 52: 1-24.
35. Centers for Disease Control and Prevention. HIV/AIDS surveillance Report, 2003 (Vol. 15). Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention;2004:1-46, Also available at: http://www.cdc.gov/hiv/stats/hasrlink.htm.
36. Hall HI, Li J, McKenna MT (2005) HIV in predominantly rural areas of the United States. J Rural Health 21: 245-253.
37. Kitahata MM, Van Rompaey SE, Dillingham PW, Koepsell TD, Deyo RA, et al. (2003) Primary care delivery is associated with greater physician experience and improved survival among persons with AIDS. J Gen Intern Med 18: 95-103.
38. Health Resources and Services Administration. Title I - Grants to Eligible Metro Areas. http://hab.hrsa.gov/programs/factsheets/ title1fact.htm (last accessed August 22, 2005).
39. Kaiser Family Foundation 0 Total Ryan White CARE Act Funding, FFY 2004. http://www.statehealthfacts.kff.org (last accessed August 22, 2005)..
40. Gange SJ, Kitahata MM, Saag MS, Bangsberg DR, Bosch RJ, et al. (2007) Cohort Profile: The North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). Int J Epidemiol.
41. Institute of Medicine. Measuring what matters: Allocation, Planning, and Quality Assessment for the Ryan White CARE Act. National Academies Press: Washington, D.C. 2004; pp 1-302.
42. Frankel MR, Shapiro MF, Duan N, Morton SC, Berry SH, et al. (1999) National probability samples in studies of low-prevalence diseases. Part II: Designing and implementing the HIV cost and services utilization study sample. Health Serv Res 34: 969-992.
43. Shapiro MF, Berk ML, Berry SH, Emmons CA, Athey LA, et al. (1999) National probability samples in studies of low-prevalence diseases. Part I: Perspectives and lessons from the HIV cost and services utilization study. Health Serv Res 34: 951-968.
44. Sullivan PS, Karon J, Malitz F, Broyles S, Mokotoff ED, et al. (2005) A two-stage sampling method for surveillance of individuals in care for HIV infection in the United States. Public Health Rep 120: 230-239.
45. Centers for Disease Control and Prevention. Guidance for HIV {revention Community Planning. 2003. Atlanta: Centers for Disease Control and Prevention, Available at: http://www.cdc.gov/hiv/pubs/hiv-cp.htm (last accessed August 18, 2005).
46. US Department of Health and Human Services. Healthy People 2010. Understanding and Improving Health and Objectives for Improving Health. 2nd ed, Vol.1 2000. Washington, DC: US Government Printing Office.
47. Health Resources and Services Administration. Government Performance Results Act Final FY 2005 Annual Performance Plan. Available at: http://www.hrsa.gov/perplan/ (last accessed August 30, 2005).
48. Centers for Disease Control and Prevention. HIV Prevention Strategic Plan through 2005. 2001. Atlanta: Centers for Disease Control and Prevention, Available at: http://www.cdc.gov/nchstp/od/hiv_plan/ default.htm (last accessed August 18, 2005).
49. Centers for Disease Control and Prevention (2003) Advancing HIV prevention: new strategies for a changing epidemic-United States, 2003. MMWR Morb Mortal Wkly Rep 52: 329-332.
50. Holmberg SD, Moorman AC, Von Bargen JC, Palella FJ, Loveless MO, et al. (1998) Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) Investigators. JAMA 279: 384-386.
51. Moormann AC, Von Bargen JC, Palella FJ, Holmberg SD (1998) Pneumocystis carinii pneumonia incidence and chemoprophylaxis failure in ambulatory HIV-infected patients. HIV Outpatient Study (HOPS) Investigators. J Acquir Immune Defic Syndr Hum Retrovirol 19: 182-188.
52. Moorman AC, Holmberg SD, Marlowe SI, Von Bargen JC, Yangco BG, et al. (1999) Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS). Ann Epidemiol 9: 349-357.
53. Weidle PJ, Holmberg SD, DeCock KM (1999) Changes in HIV and AIDS epidemiology from new generation antiretroviral therapy. AIDS 13 Suppl A: S61-8, S61-S68.
54. Matthews GW, Churchill RE (2000) Public health surveillance and the law. In: Teutsch SM, Churchill RE, eds (2000) Principles and practice of public health surveillance. New YorK: Oxford University Press. pp 215-228.
55. Health Education and Research Trust. HIV laws of individual states [website]. Available at http://www.hret.org/hret/about/hivmap.html. Last acccessed May 22, 2007.
56. Gostin LO, Lazzarini Z, Flaherty KM. Legislative Survey of State Confidentiality laws, with Specific Emphasis on HIV and Immunization. Available online at: http://www.critpath.org/msphpa/ctse.txt (last accessed on June 30, 2005).
57. PHS Act 42 USC 242m[d]. Available at: http://www2.law.cornell.edu/uscode/ uscode42/usc_sec_42_00000242-m000-.html (last accessed on May 22, 2007).
58. Centers for Disease Control and Prevention (2003) HIPAA Privacy Rule and public health: guidance from CDC and the US Department of Health and Human Services. MMWR 52(Supl): 1-20.
59. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report, 2005 (Vol. 17). Atlanta: US Department of Health and Human Services, Centers for Disease Control and Prevention;2006:1-46, Also available at: http://www.cdc.gov/hiv/stats/hasrlink.htm. Last accessed January 30, 2007.